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0.0001). Also, no relationship be~Jeen FC and culpdt stenosis (measured by 
quantitative angtography) was found (r = 0.17, p = 0.3). Thallium score was 
similar in pts with TIMI II (1.3:1: 0.8) and TIMI fll flow (1.2 • 0.8, p = 0.9). 
Conclusion: Angiographlc assessment of myocardial porfusion in the in- 
fact related artery does not correlate with ecintigraphic assessment of my- 
ccardial viability and, therefore, does not appear to otter an advantage com- 
pared to TIMI flow grading. 
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~ Initial and Six Months Outcome of Palmaz-Schatz 
Stsnt Implantation: STRESSIBenestsnt Equivalent 
Vs Non-equivalent Lesions 
Yoshihiro Saweda, Hidayuki Nosaka, Takashi Kimura, Masaklyo Nobuyoshi. 
ICitakyushu, Kokura Memorial Hospital, Japan 
To assess efficacy of the Palmaz-Schatz stent (PS) for lesions (las) currently 
exctuded from randomized trials, the immediate and 3-6 months (M) fo,ow 
up (FU) results were compared between Stress/Benestent (S/B) equivalent 
les (n = 152) and Nen-S/B las (n = 593): Small vessel (Ref. D < 3.0 mm, n = 
236), Long los (length > 15 mm, n = 125), Ostial lee (n = 97), Total occlusion 
(n = 40), Vein graft (n = 52). Rastenotic les (n = 301), Poor LV (n: 96). Before 
Jut. 1994, 700 patients (pts) (745 le.) undenNant PS implantation and 3-6 M 
FU quantitative angiogrephy was performed in 689 lee (93%). 
SAT D/G/M Rsste. TLR MLD (mm) 
(%) (%) (%) (%) pro post FU 
S/8 Equiv- 
alent 1.3 6.6 11 8.0 O.9:EOA 3.0:J:0.4 2.3±0.6 
Non-S/B 
Small 1.5 8.0 30* 19" 0.74-0.4* 2.6+0.4* 1.7:1:0.7" 
Long %6 4,8 32* 15 0.6~0.5" 2.84-0.6* 1.94-0.9" 
Ostlal 2.1 11" 40* 14 0.7±0.5* 2.9~0.5 ° 1.8"1"1.0 * 
Total 0 2.5 40 ° 7.5 O.0±0.1* 2.7~:0.7' 1.6:~0.9 ° 
Vein 0 5.8 .°,4" 21" 0.9-1-0.6 3.2:E0.5" 2.1~1.1 
Rests. 1 4.0 27* 15" 0.8±0.4 ° 2.9~0.5" 1.9:1:0.8 ° 
PoorLV 3.1 14 19 14 0.7-~0.5" 3.08-0.5 2.1 ±0.8 
SAT: .qubacute hrombosis. D/C/M: Death/CABG/MI at 7 M. Reste: Binary restenosls at 7 
M. TLR: Target lesion revassularizntion at 7 M. °p < 0.05 compared with Stmss/Benestent 
Equivalent los. 
Conclusion: S/B equivalent los constituted relatively small fraction of los. 
treated in clinical practices. Immediate results of Non-S/B equivalent los were 
similar to those of S/B equivalent las. However, FU results of Non-S/S lesion 
were not comparable to those of S/B les. 
~ Coronary An Unreported Complication Perforation: 
After Intracoronary Stent Implantation 
Kalth H. Banzuly, Sue Glazier, Cindy L. Gdnas, William W. O'Neill, Robert 
D. Safian, William Beaumont Hospital, Royal Oak MI 
Coronary artery perforation isan uncommon complication after pemutanecus 
intervention, and has not been reported after slant Implantation. To determine 
the incidence of perforation associated with stsnting, we reviewed all stsnt 
p;ocedures between September, 1993 and May 31, 1995. Among 928 stsnts 
deployed in 435 patient here were 10 perforations (2.3%; 6 Palmaz-Schatz, 
2 b11iary, 4 Giantumo-Roubin). Stsnt implantation was planned in 3 cases 
and unplanned in 7 cases (due to severe dissections after another device). 
Anglogrephlo features associated with perforation i cluded ACC/AHA B2 or C 
lesion morphology (80%); small vessel dlametsr (2,6 :l: 0,2 ram); oversized 
slants (StentJArtery ratio 1,4 4- 0.1); tapering vessel (40%); and need to 
recross a dissection with a guldewire (20%). Major clinical sequelae included 
cardiac tamponede (50%), myocardial infarction (40%), emergency surgery 
(50%), and death (30%). Two cases of tamponede occurred between 5-24 
hours after stent deployment in patients without angiographic evidence of 
perforation. 
In conclusion: Coronary perforation is uncommon after stent implantation 
but may occur in the setting of antecedent severe dissection in small vessels 
treated with oversized stsnts. Careful attention to stent size and avoiding 
high pressure inflations outside the stent may prevent stent-pedoretion. 
~ Coronary Stsnting Elderly Patients. Results In 
From the Stent Without Coumsdin French Registry 
Thlemj Lefbwe, Made-claude Modce, Bernard Labronie, Yves Chabdl;at, 
Yves Gu6dn, Remy Pillibre, Yves Louvard, Max Amor, C--,aGtsn Kadllon, 
Edgar Benvenists. ICV Paris Bud, France 
To evaluate the results of coronary stent placement in aldedy patients, a 
retrospective analysis of the 2901 Pts (mean age: 61.2 + 10.6 years) included 
from March 1991 to March 1995 in the Stent Without Coumadin French 
RegisW was performed. 
Tictopldine (250-500 mg/day) was given Ihe day of PTCA for 1 month, 
aapidn (100-250 rag/day) for > 6 months and low molecular weight hepadn 
(antiXa 0.5-1) for 1 month in phase II (237 Pts), 15 days in phase III (521 
Pts), 7 d~ys in phase IV (960 Pts) and not given in phase V (1183 Pts). 
The study group include 245 Pts (8.4%) aged ~ 75 years. Nineteen % 
were female, 49% had unstable, 8% Post M.I ischemla, 2"/0 acute M.I and 
41% stable angina. Indication for stenting was respectively: de novo lesion 
(27%), restenosts (17%), suboptimal result (2~), non occlusive dissection 
(24%) and occlusive dissection (11%). Stented coronary artedas were LAD: 
44%, RCA: 33%, Cx: 10%, L.M: 2% and Bypass: 2%). Palmaz-Schatz stents 
were used in 79% of cases, AVE stents in 16% and other stonts in 5%. One 
stent was used in 80% of cases and more than 1 in 20%. Balloon used for 
slanting was 3.32 -I- 0.38 mm in diameter with a mean inflation pressure of 
12,3:1:3.0 aim. At 1 month follow-up, vascular complication occurred in 2% 
of cases (requidng surgery in 1.2%), acute closure in 0.4%, subacute closure 
in 1.6%, emergency CABG in no case, acute M.I in 1.6%, stroke in 0.4% 
and Geath in 3%. The composite nd-point of subacute closure, acute M.I., 
CABG and death occurred in 5% of cases. 
In conclusion: coronary stsnting without coumadin seems to be a safe 
approach in eldedy patients. 
[975"~ Coronary Angioplesty Versus Primary Stent 
Placement for Isolated Proximal Left Anterior 
Descending Coronary Artery Stenesls 
Achille Gaspardone, Francesco Versact, Fabdzio Tomai, Anna De Fazio, 
Giovanni Colantuono, Mada lamele, Pier A. Gioffr& Divisione di 
Cardiochlrurgia, Universit~ Tot Vergata, Rome, Italy 
P,oximal left antedor descending coronary artery (LAD) stsnosis cardas a 
poor prognosis. Coronary angioplasty (PTCA) has been shown to be a suit- 
able alternative to left internal mammary artery grafting which is considered 
to be the standard treatment. However, no data are available concerning pd- 
mary stsnt (S) placement. To this end we have carded out a prospective study 
aimed at compadng the efficacy of PTCA or S placement in the treatment of 
patients (pts) with isolated proximal LAD stenosis. Eligible pts were randomly 
assigned to PTCA (56 pts; mean age 57:1:10 ym) or S (Palmaz-Schatz) 
placement (60 pie; 57 :J: 9 yre). Pro-intervention clinical and hemodynamic 
variables did not differ between groups. Follow-up anglograms were obtained 
in 80%o f PTCA-treated 10ts and in 87% of S-treated pts. Procedure and early 
and 12-month clinical outcomes were as follows (mean values): 
PTCA S 
Vessel diameter ( am) 3.1 3.2 NS 
Baseline % diameter stenosis 92 91 NS 
Rnal % diameter tenosls 20 3 p = 0.001 
Procedure success (%) 95 97 NS 
In-hospital complication (%) 0 6 NS 
12-monlh restanosis rata (%) 40 19 p = 0.04 
12-month event-free survival (%) 69 90 p = 0.02 
Thus, the findings of this study indicate that, in symptomatic pts with 
proximal LAD stsnosis, primary S placement, compared to PTCA, showed: 
1) a superior initial angiogrephic result; 2) a lower 12-month restenosis rate 
and 3) a more favorable 12-month clinical outcomes. 
~ 1  Rotational Atherectomy Prior to Stsnt Implantation 
Ermlnia M. GuamerL Shela L. Norman, K. Michelie Stevens, 
Oscar Mathews, Richard A. Schatz, Paul S. Teirstsin. Scripps Clinic and 
Research Foundation, La Jolla, CA 
The safety and efficacy of Palmaz-Schatz stents for the treatment of subop- 
timal rotational therectomy (RA) results or as an adjuvant to RA for calcified 
coronary lesions was assessed in 127 pts. In 50% slants were planned. In 
50% slants were placed for suboptimal RA results. The planned and un- 
planned stent groups were similar in AHA/ACC Lesion Class: B1 25%, B2 
43%, C1 32%, mean distal reference diameter (2.75 mm) and mean lesion 
length (7.453 ram). Vessels treated: LAD 34%, RCA 36%, circumflex 21%, 
protected teit main 7%, unprotected left main 2%. High-pressure (> 16 aim) 
bellonn inflation was performed in all stsnts. Procedural success (< 50% di- 
ameter stenosis without Q-wave MI, bypass surgery or death) was achieved 
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in 9S%. There were 3 Q-wave infarcts (3%) and 1 death (1%). A non-Q-wave 
infarct was sustained by 610ts (5%) and 1 lot (1%) required emergency bypass 
surge~'. 
The pro and final MLO for both groups was 0.72 and 2.75 mm (diameter 
eten~ls of 76.8 and -11.4%). Patients were discharged on aspirin (ASA) and 
werfadn 54%, ASA and t i~ id ine  42%, or ASA, tioiopkiine and low molecular 
weight hepadn 4"/,,. Mean 18-month follow-up on 7"P/o demonstrated: t vget 
lesion retntervention 5%, CABG 3%, stunt thrombosis 0%, death 5%. 
Conclusion: Stunt deployment for suboptimal RA results or as an adjunct 
treatment of calcified coronary lesions provides excellent angiographic re- 
suits (-11.4% final etenosis') with few major procedural complications. 
r9-7-~-7-7-4--i coronary stunt  Implantation in Aorto-Ostlal 
Lesions: Immediate end Follow-up Results 
Antonio Colombo, Akim Iteh, Luigi Malello, Stmanefta Blengine, Carlo Di 
Made, Zamptsd Pa~fo, Lucia Di Francesco, Massimo Fenaro, 
Giovanni Martini, Leo Fincl. Columb,.-s Hospital, Milan, Italy 
Treatmem of aorto-oetial lesions by conventional balloon angioplesty and 
other new devious (laSer, atherectomy devices) is limited by high restenosis 
rates of up to 60=/0, This study evaluate immediate and long-term results of 
stem implantation in aorto.oetial lesions. We treated 35 astial lesions In 35 
patients (mean age 61 4.13 years, 88=/., males). The lesion distribu~on was: 
17 ostial RCA, 13 aspheneus vein graft aorto-ostlal anastomoses and 5 estlal 
Left Main lesions. Stem indications were: 23 elective (66%), 6 restenosis 
(17%), 5 s,JbOptimel PTCA result (14"/o) and 1 dissection (3%). Procedural 
success was aChieved in all attempted procedures. Retablater was performed 
prior to stunting in 6 patients. A total of 41 stants were implanted: 21 standard 
Palmaz-Schetz, 12 short Palmaz-Schatz, 6 bilimy Patmaz-Schata, 1 Wiktor 
and 1 Gianturoo-Roub|n stunt. Angiographic results are shown in the table: 
Baseline Post s tem Follow-up 
MLD (ram) 0.85 4- 0.62 3.51 4. 0.65 2.48 4. 0.83 
%Stanosis 75.2 4-17,8 -9.2 4. 22.9 26,1 4-19,3 
MLD - minimal lumen diameter 
Angiographic tollow-up was performed in ~J r~iients (69% of eligible 
patients) and restenosis occurred in 5 lesions (2"o'%). Conclusion: Stenting 
of suitable aorto-ostial lesions has favorable immediate and medium-term 
results and a I(~,ver estenosis rate compared to the hlstodcal group of 
patients having treatment by other interventions. 
~ A  Highly Signif icant 40% Reduction in lachemic 
Complications of  Percutaneous Coronary 
Intervention In 19~5: Beginning of  A New Era? 
Stephsn G. Ellis, Patrick L. Whitlow, ViCtor Guetta, W, Scott Sheldon, Edc 
J. Topoi. The Cleveland Clinic Foundation, Cleveland, OH 
1995 was marked in the U.S. intewentionel community by a dramatic upswing 
In the number ot patients (pts) treated (rx'd) with elective sterile, and the first 
availability of the anttplatalet agent ReoPro. At our center, physicians also 
were tracked for the first time by pt cost. By mid-year we noted a considerable 
reduction in ischemio events and this study was formally undertaken to 
assess differences in pt oemngraphlca nd outcome for 1995 compared to 
1993-94. Pte presenting with acute MI were excluded. 
1993-94 (n = 3732) 1-8/1995 (n - 1269) ,,p 
Age firs) 62 4-11 64 4-11 < 0,001 
Angina t re,3t (%) 41.7 43.1 0.36 
Most complex I~inn 82 or C (%) 58.5 51.0 < 0.001 
Elective stunt (%) 4,8 22.8 < 0.001 
ReoPro (%) 0.0 7.0 < 0.001 
Cardiao death (%) 0.8 0.6 0.61 
Emerg CABG (%) 1.4 0,8 0.06 
O wave Mt (%) 1.3 0,5 0.003 
Death, Q wave MI, Emerg CABG 3.0 1.7 0.004 
Logistic analysis disregarding any particular x, but correcting for 11 vari- 
ables [including most complex lesion: odds ratio (OR)/unit (A = 1, B1 = 2, B2 
= 3, C = 4) = 2.4, p < 0,001; pdor CABG:OR = 0.6, p = 0.005; and shock: 
OR - 3.1 p = 0.006] found rx in 1995 still to be related to dsk of death, MI or 
CABG (OR = 0.6, p = 0.05). Rx in 1995 became dearly unrelated to outcome 
(OR = 0.8, p = 0.28) when the vadable "stunting in 1995" was added. 
Conclusions: Complications of porcelaneous intervention appear to be 
reduced in 1995, possibly due to a decrease in lesion complexity, more 
elective stunting and ether factors. 
• Elective Coronary Stenting Versus Bal loon 
Angloplesty In Smaller Native Coronary Arteries: 
Results  From STRF.S~ 
Michael Savage, David Fischman, Randal Rake, Richard Schetz, fen Penn, 
Masakiyo Nobuyoshi, Jeffrey Moses, Richard Heuser, Sharon Gebhardt, 
Sheldon Goiolcorg for the STRESS Tdal Investigators. Jefferson Medical 
College, Philadelphia PA 
Palmaz-Schalz stunts have been designed and FDA-approved for large 
comneW arteries with diameters >_. 3.0 ram. The goal of this STRESS Trial 
substudy was to comp~e the egicacy of elective stem implantation and 
angioplasty (PTCA) for new lesions in smaller native coronary arteries. Of 
407 patients enrolled in this prospective random!zed trial, 214 (,5,~0) patients 
were determined by core laboretonj quantitative analysis to hove reference 
vessel dlametem < 3.0 ram. 111 patients were assigned to PTCA (mean 
diameter 2.65 ~- 0.24 ram) and 103 patients were -ssigned to stenting (mean 
diameter 2.71 4. 0.21 ram). Endpoints were analyzed by intention-to-treat. 
Bese(ine clinical ~ lesion charectsfistlcs were comparable for the two 
groupS. Abrupt closure (in or out of lab) occurred in 3(2.7"/o) patients Ip the 
PTCA group and 4(3.9%) patients in the stant group (p = ns). Minimal umen 
diameters in mm were as follows: 
Group Baseline Post Procedure 6 month F/U Net Gain 
PTCA 0.68:1:0.21 1.784-0.36 1.304-0.52 0.634-0.53 
Stem 0.72 4- 0.25 2.29 4- 0.38 1.56 ± 0.56 0.84 ± 0.59 
p ns <0.0001 0.001. 0.013 
Thus, stunting conferred a larger initial lumen which persisted after 6 
months. Restenosts (> 50% dian;eter ste~lnsis at foi;ow-up) occurred in 
44/84(52%) patients assigned to PTCA and in 3~'93(35%) patients assigned 
to stunting (p = 0.024). There were no significant differences in clinical events 
between the two groups. Target lesion revascutarizat~on was performed in 
25(23%) PTCA patients and 16(16%) stent patients (p = ns). In conclu- 
sion, the results of this STRESS Tdal substudy suggest that elective .~tent 
placement provides supedor angiogrephic outcome and less restenosis than 
PTCA in vessels slightly smaller than 3 ram. 
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~7-~'~ High Plasma Angiotensin-ConverUng Enzyme 
Levels, and Insell ion/Deletion Genotype Are 
Aesoclated With Reatenosla After Coronary 
Stenting 
Ravlo Ribtchini, Giusoppa Stalfenino, Antonio Dellavalle, 
Terenzio Camilla 1, Alberto Piazza 2, Gabfiella Benetton 2 Pine Malullo 2 
Eugenio Uslanghi. C.ard/ac Cathete~ation Unit, Italy; ~ Laboratory for 
Clinical Biochemistry, Ospedale S. Croce, Cuneo, Italy: 2 Ins~tute of Human 
Genetics, Univers;~ : ,of Turin, Italy 
Angiotansln-cenvarting enzyme (ACE) I/D ganotype does not appear to be 
consistently associated with restenosis attar balloon coronary angioptasty. 
The ACE genotypa determines plasma levels of the enzyme. Via Angioton- 
sin II, ACE can promote smooth muscle cell proliferation. This is reported 
to be the most important component of restenosts after coronary stenting 
(CS), but not after buffoon dilatation. We investigated the relationship be- 
tween ACE plasma levels, I/D ACE genutype, and tong-term restenosls after 
CS. 
Sixty-three consecutive patients (p) were treated with a first, elective, 
single-vassal CS. Basal plasma ACE levels were measured with a quan- 
titottve kinetic determination using FAPGG substrata (mean normal values 
30 + - 10 U/L), and a complete laboratory screening was obtained in all p. 
Amplification by polymerase chain reaction was used in the determination of 
ACE gone polymoqDhism. No p received ACE-inhibitor therapy thmughou; 
the study. Restanosls was defined as the presence of • 50% stenosis of 
the treated lesion, as measured with a Philips DCI Quantitative Coronary 
Angiogrephy system at 6-month angiographio follow-up. Plasma ACE lev- 
els and I/D golymorphtsm in p with and without restenosis were as follows 
(percentages in brackets): 
No. ACE(U/L) D/D UD 111 
Restanosls 13 47.3 4- I"P 11 (85)" 2 (15) 0 
No Restenosls 50 20.5 4-11 # 15 (30)" 25 (50) 10 (20) 
#p < 0.0001; Up < 0.001 
